OCWP
CAI

Owl Creek Wealth Partners’s Caris Life Sciences CAI Stock Holding History

Owl Creek Wealth Partners’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45K Buy
530
+340
+179% +$6.09K ﹤0.01% 867
2026
Q1 		$3.4K Buy
+190
New +$4.15K ﹤0.01% 1056

Other funds holding CAI

JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Owl Creek Wealth Partners's CAI Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its Caris Life Sciences (CAI) stake by 179% in Q2 2026, buying an estimated $6.09K and bringing the position to 530 shares worth $9.45K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Owl Creek Wealth Partners first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Owl Creek Wealth Partners held 530 shares of Caris Life Sciences worth $9.45K as of Q2 2026.
  • Owl Creek Wealth Partners bought 340 Caris Life Sciences shares in Q2 2026, an estimated $6.09K.
  • Caris Life Sciences made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #867 holding.
  • Owl Creek Wealth Partners first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.